[Off-label use of vincristine for intralesional treatment of isolated papules in Kaposi's sarcoma: Dermatologic experience with 10 patients]

Ann Dermatol Venereol. 2020 Feb;147(2):140-143. doi: 10.1016/j.annder.2019.10.022. Epub 2019 Dec 4.

[Article in French]

Authors

T Peduto¹, G Fabbrocini¹, M Delfino¹, P Nappa¹, M Guarino¹, F Cillo²

Affiliations

¹ Université de Naples Federico II, Département de, Dermatologie Clinique, via Pansini 5, 80138 Naples (NA), Italie.
² Université de Naples Federico II, Département de, Dermatologie Clinique, via Pansini 5, 80138 Naples (NA), Italie. Electronic address: fr.med.17@gmail.com.

PMID: 31810583
DOI: 10.1016/j.annder.2019.10.022

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Antineoplastic Agents, Phytogenic / administration & dosage*
Antineoplastic Agents, Phytogenic / adverse effects
Female
Humans
Injections, Intralesional
Male
Middle Aged
Mouth Neoplasms / drug therapy*
Mouth Neoplasms / pathology
Mouth Neoplasms / virology
Off-Label Use*
Sarcoma, Kaposi / drug therapy*
Sarcoma, Kaposi / pathology
Sarcoma, Kaposi / virology
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology
Skin Neoplasms / virology
Vincristine / administration & dosage*
Vincristine / adverse effects

Substances

Antineoplastic Agents, Phytogenic
Vincristine